loadpatents
Patent applications and USPTO patent grants for Monsonego; Alon.The latest application filed is for "kits, compositions and methods for evaluating immune system status".
Patent | Date |
---|---|
Kits, Compositions And Methods For Evaluating Immune System Status App 20220196677 - Monsonego; Alon ;   et al. | 2022-06-23 |
Methods for generating immunotolerant responses Grant 11,123,404 - Cohen , et al. September 21, 2 | 2021-09-21 |
Three Dimensional Clusters Of Transdifferentiated Cells, Compositions And Methods Thereof App 20210171915 - ASSA KUNIK; Efrat ;   et al. | 2021-06-10 |
Non-cytotoxic Modified Cells And Use Thereof App 20190233516 - MONSONEGO; Alon ;   et al. | 2019-08-01 |
Compositions And Methods For Generating Immunotolerant Responses App 20190008924 - COHEN; Smadar ;   et al. | 2019-01-10 |
T-cell therapy to neurodegenerative diseases Grant 10,117,895 - Monsonego November 6, 2 | 2018-11-06 |
Molecular diagnostic kits for evaluating stress Grant 9,664,690 - Monsonego , et al. May 30, 2 | 2017-05-30 |
Vaccine for alzheimer's disease Grant 9,345,753 - Monsonego , et al. May 24, 2 | 2016-05-24 |
T-cell Therapy To Neurodegenerative Diseases App 20130280224 - Monsonego; Alon | 2013-10-24 |
Amyloid Beta-peptides And Methods Of Use Thereof App 20110178024 - Monsonego; Alon | 2011-07-21 |
Vaccine For Alzheimer's Disease App 20110076323 - Monsonego; Alon ;   et al. | 2011-03-31 |
Amethod Of Treating Neurodegenerative Diseases App 20100272787 - Monsonego; Alon | 2010-10-28 |
Novel Neuroprotective Compounds and Uses Thereof App 20100144868 - Gozin; Michael ;   et al. | 2010-06-10 |
Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease Grant 7,560,102 - Eisenbach-Schwartz , et al. July 14, 2 | 2009-07-14 |
Amyloid beta-peptide and methods of use App 20050123553 - Monsonego, Alon ;   et al. | 2005-06-09 |
Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease App 20040253218 - Eisenbach-Schwartz, Michal ;   et al. | 2004-12-16 |
Activated T-cells, Nervous System-specific Antigens And Their Uses App 20030108528 - EISENBACH-SCHWARTZ, MICHAL ;   et al. | 2003-06-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.